A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo
Phase 4
Completed
- Conditions
- Osteoporosis
- Registration Number
- NCT02948881
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
The purpose of this study is to estimate the effect of oral Boniva (ibandronate sodium)taken once monthly versus placebo on bone quality and strength at the hip at one year.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Bone quality and strength at the hip by characterizing changes in trabecular and cortical bone quality using Volumetric Quantitative Computed Tomography (vQCT) and novel imaging analysis methods, including a subset of bone biopsies for one year. 1 Year
- Secondary Outcome Measures
Name Time Method Relationship between biomarkers and changes in bone quality for one year. 1 Year
Trial Locations
- Locations (1)
GSK Investigational Site
🇺🇸Duncansville, Pennsylvania, United States